Previous 10 | Next 10 |
This is Psychedellux, the week’s top news in the psychedelic industry Psychedelic medicine company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the fourth quarter and year-end 2020 and gave an update on recent progress across its ...
The world is in desperate need for new treatments for major issues, such as mental health and obesity. That’s where companies, such as NeonMind Biosciences ( CSE:NEON) (OTC:NMDBF), Cybin Inc. (NEO:CYBN)(OTC:CLXPF), Tryp Therapeutics Inc. (CSE:TRYP), Mind Medicine Inc. ...
Image source: The Motley Fool. COMPASS Pathways plc (NASDAQ: CMPS) Q4 2020 Earnings Call Mar 09, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: COMPASS Pathways plc (CMPS) Q4 2020 Earnings Call Transcript
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 9, 2021 – The mental health treatment space is heading into a period of incredible innovation. New therapies and unconventional pharmaceuticals are receiving serious attention ...
Psychedelic medicine company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the fourth quarter and year-end 2020 and gave an update on recent progress across its business. Compass delivered a net loss for the quarter ending in December 2020 was $18.8 mi...
COMPASS Pathways ADS (CMPS): Q4 GAAP EPS of -$0.52 misses by $0.16.Cash and cash equivalents of $190.3MPress Release For further details see: COMPASS Pathways ADS EPS misses by $0.16
LONDON, March 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter and year-end 2020 and gave an upda...
It might seem rather odd to invest in a company investigating a psychedelic drug candidate, a hyped-up electric vehicle (EV) manufacturer, or a flower vendor. But often, it can pay off handsomely to have investment interests that are distinct from others or packed with growth potential. T...
Palm Beach, FL – March 2, 2021 – Many people and investors may be confused, thinking that the Psychedelics market is part of the cannabis market. It is not a way to get higher ‘highs’ in the legal cannabis market… it will make its mark in medicine. Various...
Psychedelics, like ketamine could be a game-changer for the medical community. In addition to psilocybin, MDMA, LSD, and cannabis, ketamine could be beneficial, as well. According to the Psychological Care & Healing Center, “Ketamine, a widely used anesthetic medication, is now b...
News, Short Squeeze, Breakout and More Instantly...
2024-08-01 23:30:19 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q2 2024 Earnings Call Aug 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Tr...
Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024 Gino Santini to join Board of Directors as Chairman Lori Englebert named new Chief Commercial Officer Cash position of $228.6 million ...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...